ResMed | RMD - Selling And Administration Expenses

Stock Price
36.29
Daily Change
-0.77 -2.08%
Monthly
-0.55%
Yearly
-6.85%
Q1 Forecast
36.78

ResMed reported $275.7M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Ansell USD 267.2M 8.5M Jun/2025
Avita Medical AUD 20.98M 253K Jun/2025
Cochlear AUD 234.95M 235.05M Jun/2025
CSL USD 727M 453M Jun/2025
Fisher & Paykel Healthcare NZD 285.5M 11.6M Dec/2025
Healius AUD 393.4M 378.35M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Nanosonics AUD 26.85M 23.41M Jun/2025
Polynovo AUD 21.13M 18.27M Jun/2024
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Regis Healthcare AUD 505.42M 18.5M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Sigma Healthcare AUD 134.77M 9.73M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024